Post-authorization safety surveillance of a liquid pentavalent vaccine in Guatemalan children

Vaccine

Volumn 31, Issue 49, 2013, Pages 5909-5914

  Asturias, Edwin J ^a,b,d   Contreras Roldan, Ingrid L ^c   Ram, Malathi ^d   Garcia Melgar, Ana J ^e   Morales Oquendo, Vilma ^e   Hartman, Katharina ^f   Rauscher, Martina ^f   Moulton, Lawrence H ^d   Halsey, Neal A ^d  

^a Nutrition Obesity Research Center at the University of Colorado   (United States)

^b Department of Civil and Environmental Engineering at Colorado State University and the Department of Environmental and Occupational Health at the Colorado School of Public Health   (United States)

^c Center for Health Studies   (Guatemala)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e Department of Pediatrics   (Guatemala)

^f CRUCELL HOLLAND BV   (Netherlands)

Author keywords

DTP; Hib; Liquid pentavalent; Post licensure surveillance; Safety

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; ORAL POLIOMYELITIS VACCINE; RECOMBINANT HEPATITIS B VACCINE;

ALLERGIC REACTION; ARTICLE; BRAIN HEMORRHAGE; BRONCHOPNEUMONIA; BRONCHUS HYPERREACTIVITY; CAUSE OF DEATH; COHORT ANALYSIS; CONSULTATION; CONVULSION; DIARRHEA; DRUG MONITORING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EMERGENCY WARD; FALLOT TETRALOGY; FEMALE; FOLLOW UP; GUATEMALA; HOSPITALIZATION; HUMAN; INCIDENCE; INFANCY; INFANT; INFANT MORTALITY; INJECTION SITE REACTION; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MORTALITY; MULTIPLE ORGAN FAILURE; OBSERVATIONAL STUDY; OPEN STUDY; PNEUMONIA; POPULATION; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFERENCE VALUE; RHINOPHARYNGITIS; RISK FACTOR; SEPSIS; SEPTIC SHOCK; SIDE EFFECT; SUDDEN INFANT DEATH SYNDROME; VACCINATION;

DTP; HIB; LIQUID PENTAVALENT; POST LICENSURE SURVEILLANCE; SAFETY;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; GUATEMALA; HAEMOPHILUS VACCINES; HEPATITIS B VACCINES; HOSPITALIZATION; HUMANS; IMMUNIZATION; IMMUNIZATION PROGRAMS; INFANT; MALE; PRODUCT SURVEILLANCE, POSTMARKETING; PROSPECTIVE STUDIES; VACCINES, COMBINED;

EID: 84887609999     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.09.015     Document Type: Article

References (26)

1. Brown D.W., Burton A., Gacic-Dobo M., Karimov R.I., Vandelaer J., Okwo-Bele J.M. A mid-term assessment of progress towards the immunization coverage goal of the Global Immunization Vision and Strategy (GIVS). BMC Public Health 2011, 11:806.
2. World Health Organization (WHO) The children's vaccine initiative and the global programme for vaccines and immunization - recommendations from the special advisory group of experts, Part I. Wkly Epidemiol Rec 1996, 71:261-266.
3. Combination vaccines for childhood immunization. MMWR Recomm Rep 1999, 48:1-14.
4. Duclos P., Bentsi-Enchill A. Current thoughts on the risks and benefits of immunisation. Drug Saf 1993, 8:404-413.
5. Muehlhans S., Richard G., Ali M., Codarini G., Elemuwa C., Khamesipour A., et al. Safety reporting in developing country vaccine clinical trials-a systematic review. Vaccine 2012, 30:3255-3256.
6. Andrews N.J. Statistical assessment of the association between vaccination and rare adverse events post-licensure. Vaccine 2001, 20(Suppl. 1):S49-S53. discussion S45-8.
7. Kanra G., Kara A., Demiralp O., Contorni M., Hilbert A.K., Spyr C., et al. Safety and immunogenicity of a new fully liquid DTPw-HepB-Hib combination vaccine in infants. Hum Vaccin 2006, 2:155-160.
8. Suárez E., Asturias E.J., Hilbert A.K., Herzog C., Aeberhard U., Spyr C. A fully liquid DTPw-HepB-Hib combination vaccine for booster vaccination of toddlers in El Salvador. Rev Panam Salud Publica 2010, 27:117-124.
9. ®: the first 5 years. Vaccine 2012, 30:6241-6248.
10. World Health Organization (WHO) Report of a WHO ad hoc expert panel to review reports of serious AEFI following administration of pentavalent and other vaccines - Sri Lanka 2008, Available at:, [accessed 14.5.13]. http://jacob.puliyel.com/download.php%3Fid=213.
11. Bonhoeffer J., Bentsi-Enchill A., Chen R.T., Fisher M.C., Gold M.S., Hartman K., et al. Guidelines for collection, analysis and presentation of vaccine safety data in pre- and post-licensure clinical studies. Vaccine 2009, 27:2282-2288.
12. Whitaker H.J., Farrington C.P., Spiessens B., Musonda P. Tutorial in biostatistics: the self-controlled case series method. Stat Med 2006, 25:1768-1797.
13. Wilson K., Hawken S., Potter B.K., Chakraborty P., Kwong J., Crowcroft N., et al. Patterns of emergency room visits, admissions and death following recommended pediatric vaccinations - a population based study of 969,519 vaccination events. Vaccine 2011, 29:3746-3752.
14. Brighton Collaboration. Case definitions. Available at: [accessed 14.5.13]. https://brightoncollaboration.org/public/what-we-do/setting-standards/case-definitions.html.
15. Kohl K.S., Magnus M., Ball R., Halsey N., Shadomy S., Farley T.A. Applicability, reliability, sensitivity, and specificity of six Brighton Collaboration standardized case definitions for adverse events following immunization. Vaccine 2008, 26:6349-6360.
16. Farrington C.P. Incidence estimation from case series for vaccine safety evaluation. Biometrics 1995, 51(1):228-235.
17. Ministry of Public Health and Social Welfare of Guatemala, et al. V Encuesta Nacional de Salud Materno Infantil 2008-2009. Available at: [accessed 16.5.13]. http://www.ine.gob.gt/np/ensmi/Informe_ENSMI2008_2009.pdf.
18. Buettcher M., Heininger U., Braun M., Bonhoeffer J., Halperin S., Heijbel H., et al. Hypotonic-hyporesponsive episode (HHE) as an adverse event following immunization in early childhood: case definition and guidelines for data collection, analysis, and presentation. Vaccine 2007, 25:5875-5881.
19. Gold M.S. Hypotonic-hyporesponsive episodes following pertussis vaccination: a cause for concern. Drug Saf 2002, 25:85-90.
20. Braun M.M., Terracciano G., Salive M.E., Blumberg D.A., Vermeer-de Bondt P.E., Heijbel H., et al. Report of a US public health service workshop on hypotonic-hyporesponsive episode (HHE) after pertussis immunization. Pediatrics 1998, 102:E52.
21. Vermeer-de Bondt P.E., van der Maas N.A. The effect of age and dose number on the risk of collapse (hypotonic-hyporesponsive episode) after pertussis vaccination. Pediatr Infect Dis J 2008, 27:355-357.
22. Virtanen M., Peltola H., Paunio M., Heinonen O.P. Day-to-day reactogenicity and the healthy vaccinee effect of measles-mumps-rubella vaccination. Pediatrics 2000, 106:E62.
23. Zangwill K.M., Eriksen E., Lee M., Lee J., Marcy S.M., Friedland L.R., et al. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization. Pediatrics 2008, 122(6):e1179-e1185.
24. Baraff L.J., Leake R.D., Burstyn D.G., Payne T., Cody C.L., Manclark C.R., et al. Immunologic response to early and routine DTP immunization in infants. Pediatrics 1984, 73:37-42.
25. Monteiro S.A., Takano O.A., Waldman E.A. Surveillance for adverse events after DTwP/Hib vaccination in Brazil: sensitivity and factors associated with reporting. Vaccine 2010, 28:3127-3133.
26. Ducusin J., Dayrit E., Simbulan A., Tuazon A. A post-marketing surveillance study of a combined diphtheria, tetanus, whole-cell pertussis, and hepatitis B vaccine in the Philippines. Southeast Asian J Trop Med Public Health 2000, 31:487-492.